• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Stocks That Hit 52-Week Lows On Monday

    8/15/22 11:36:10 AM ET
    $API
    $BFRI
    $DNAA
    $EAST
    Computer Software: Prepackaged Software
    Technology
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $API alert in real time by email

     

    On Monday, 31 companies hit new 52-week lows.

    Noteworthy Mentions In Today's 52-Week Lows:

    • The largest company in terms of market cap to set a new 52-week low was PetroChina Co (NYSE:PTR).
    • SciSparc (NASDAQ:SPRC) is the smallest company on a market cap basis to set a new 52-week low.
    • Nocera (NASDAQ:NCRA)'s stock dropped the most, trading down 15.92% to reach a new 52-week low.
    • Orion Energy Sys (NASDAQ:OESX)'s shares had the biggest turnaround, impressively rebounding 0.3% after reaching a new 52-week low.

    Stocks dropping to new 52-week lows on Monday:

    • GSK (NYSE:GSK) shares were down 4.07% for the day, having made a 52-week low of $34.43.
    • TTEC Holdings (NASDAQ:TTEC) shares set a new yearly low of $57.66 this morning. The stock was up 0.51% on the session.
    • SmartRent (NYSE:SMRT) shares were down 11.78% for the day, having made a 52-week low of $3.35.
    • Maverix Metals (AMEX:MMX) stock drifted down 3.79% on Monday morning to hit a new 52-week low of $3.80.
    • Agora (NASDAQ:API) shares hit a yearly low of $4.60. The stock was down 1.48% on the session.
    • Starry Group Holdings (NYSE:STRY) shares were down 2.58% for the day, having made a 52-week low of $2.66.
    • HomeTrust Bancshares (NASDAQ:HTBI) shares were down 0.89% for the day, having made a 52-week low of $22.86.
    • Social Cap Suvretta Hldgs (NASDAQ:DNAA) stock achieved a new 52-week low on Monday morning, hitting $9.48 and moving down 3.21%.
    • CorpHousing Group (NASDAQ:CHG) stock broke to a new 52-week low of $2.88 on Monday. Shares of the company traded down 14.05%.
    • Wag Group (NASDAQ:PET) shares moved down 4.78% on Monday to hit a new 52-week low of $7.12, drifting down 4.78%.
    • Inspirato (NASDAQ:ISPO) stock drifted down 6.17% on Monday morning to hit a new 52-week low of $3.68.
    • POET Technologies (NASDAQ:POET) stock hit a new 52-week low of $3.03. The stock was down 9.96% on the session.
    • Sierra Metals (AMEX:SMTS) stock set a new 52-week low of $0.51 on Monday, moving down 8.5%.
    • Forza X1 (NASDAQ:FRZA) shares set a new yearly low of $5.81 this morning. The stock was down 11.35% on the session.
    • Loyalty Ventures (NASDAQ:LYLT) stock broke to a new 52-week low of $2.56 on Monday. Shares of the company traded down 6.5%.
    • Orion Energy Sys (NASDAQ:OESX) shares fell to $1.63 on Monday, setting a new 52-week low with a shift of down 0.3%.
    • PLx Pharma (NASDAQ:PLXP) shares moved down 15.43% on Monday to hit a new 52-week low of $1.33, drifting down 15.43%.
    • IN8bio (NASDAQ:INAB) stock set a new 52-week low of $1.84 on Monday, moving up 1.62%.
    • Biofrontera (NASDAQ:BFRI) stock hit a new 52-week low of $1.30. The stock was down 6.38% on the session.
    • Nocera (NASDAQ:NCRA) stock set a new 52-week low of $2.00 on Monday, moving down 15.92%.
    • Eastside Distilling (NASDAQ:EAST) shares hit a yearly low of $0.52. The stock was down 12.46% on the session.
    • SciSparc (NASDAQ:SPRC) shares fell to $1.02 on Monday, setting a new 52-week low with a shift of down 6.24%.

    Be sure to monitor Benzinga for the news traders need! And for even more up-to-date info on 52-week lows and highs, check out Benzinga Pro. This cutting-edge market research platform alerts traders of which stocks are trading near their 52-week highs and lows each morning - and delivers lots of other actionable data. Learn more here.

    Get the next $API alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $API
    $BFRI
    $DNAA
    $EAST

    CompanyDatePrice TargetRatingAnalyst
    GSK plc
    $GSK
    6/3/2025Buy → Hold
    Berenberg
    GSK plc
    $GSK
    4/15/2025$35.25Neutral
    Exane BNP Paribas
    GSK plc
    $GSK
    2/12/2025Equal-Weight
    Morgan Stanley
    Agora Inc.
    $API
    1/16/2025$6.00Neutral → Buy
    BofA Securities
    POET Technologies Inc.
    $POET
    11/18/2024$6.00Outperform
    Northland Capital
    GSK plc
    $GSK
    11/15/2024Buy → Hold
    Deutsche Bank
    Wag! Group Co.
    $PET
    11/14/2024Buy → Hold
    Craig Hallum
    GSK plc
    $GSK
    11/12/2024$53.00 → $39.50Buy → Hold
    Jefferies
    More analyst ratings

    $API
    $BFRI
    $DNAA
    $EAST
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    GlaxoSmithKline downgraded by Berenberg

    Berenberg downgraded GlaxoSmithKline from Buy to Hold

    6/3/25 7:26:51 AM ET
    $GSK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Exane BNP Paribas initiated coverage on GlaxoSmithKline with a new price target

    Exane BNP Paribas initiated coverage of GlaxoSmithKline with a rating of Neutral and set a new price target of $35.25

    4/15/25 12:40:46 PM ET
    $GSK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Morgan Stanley initiated coverage on GlaxoSmithKline

    Morgan Stanley initiated coverage of GlaxoSmithKline with a rating of Equal-Weight

    2/12/25 7:05:11 AM ET
    $GSK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $API
    $BFRI
    $DNAA
    $EAST
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Director Biofrontera Ag

    4 - Biofrontera Inc. (0001858685) (Issuer)

    9/18/25 11:59:26 AM ET
    $BFRI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Chief Commercial Officer Jones George Patrick

    4 - Biofrontera Inc. (0001858685) (Issuer)

    9/16/25 9:25:47 PM ET
    $BFRI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 3 filed by new insider Jones George Patrick

    3 - Biofrontera Inc. (0001858685) (Issuer)

    9/16/25 9:23:22 PM ET
    $BFRI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $API
    $BFRI
    $DNAA
    $EAST
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Biofrontera Inc. Announces Last Patient Out in Phase 3 Study of Ameluz® (aminolevulinic acid HCI) Topical Gel, 10% Photodynamic Therapy (PDT) for the Treatment of Actinic Keratoses (AK) on the Extremities, Neck and Trunk

    All 172 patients have now entered the 12-month follow-up phaseTrial involves larger surface areas, building on the approval in October 2024 for use of up to 3 tubes of Ameluz® per treatmentStudy results expected to form the basis of a supplemental New Drug Application (sNDA) planned for submission in Q2 2026 WOBURN, Mass., Sept. 16, 2025 (GLOBE NEWSWIRE) -- Biofrontera Inc. (NASDAQ:BFRI) ("Biofrontera" or the "Company"), a biopharmaceutical company specializing in the development and commercialization of photodynamic therapy (PDT), today announced that the final patient completed the active treatment phase of its Phase 3 clinical trial evaluating Ameluz® (10% 5-aminolevulinic acid hydroch

    9/16/25 10:30:00 AM ET
    $BFRI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Orion Secures Approximately up to $11M in Electrical Infrastructure, LED Lighting and EV Charging Projects

    MANITOWOC, Wis., Sept. 16, 2025 (GLOBE NEWSWIRE) -- Orion Energy Systems, Inc. (NASDAQ:OESX) (Orion Lighting) today announced an LED lighting, electrical infrastructure and EV charging engagement, representing revenue of up to $11 million, for a longtime government agency customer. The projects, which were secured through a Super energy service company (Super ESCO) partner, are expected to be completed over the next several fiscal quarters. Orion's engagement includes installations and upgrades of electrical infrastructure, including exterior LED lighting and EV charging station solutions, for two U.S. facilities. This work may be followed by additional projects for this customer at oth

    9/16/25 8:29:00 AM ET
    $OESX
    Building Products
    Consumer Discretionary

    Inspirato and Buyerlink Announce Mutual Decision to End Merger Agreement

    DENVER, Sept. 15, 2025 (GLOBE NEWSWIRE) -- Inspirato Incorporated ("Inspirato" or the "Company") (NASDAQ:ISPO), the premier luxury vacation club and property technology company, and Buyerlink, a leader in building and operating online marketplaces, today announced that they have mutually agreed to terminate the previously announced merger agreement to combine the two companies. Inspirato will continue operating independently, with no termination fee paid by either party. "Although we believed the proposed merger with Buyerlink would have offered meaningful benefits, we also listened carefully to the perspectives of our shareholders," said Ann Payne, Inspirato's Lead Independent Director.

    9/15/25 9:00:00 AM ET
    $ISPO
    Blank Checks
    Finance

    $API
    $BFRI
    $DNAA
    $EAST
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Martell Frank bought $79,115 worth of shares (50,000 units at $1.58) (SEC Form 4)

    4 - SmartRent, Inc. (0001837014) (Issuer)

    9/16/25 5:11:32 PM ET
    $SMRT
    EDP Services
    Technology

    Chief Executive Officer Martell Frank bought $148,500 worth of shares (100,000 units at $1.49) (SEC Form 4)

    4 - SmartRent, Inc. (0001837014) (Issuer)

    9/15/25 4:16:26 PM ET
    $SMRT
    EDP Services
    Technology

    CHIEF EXECUTIVE OFFICER Zamani Payam bought $59,200 worth of Class A Common Stock (20,000 units at $2.96), increasing direct ownership by 2% to 1,170,000 units (SEC Form 4)

    4 - Inspirato Inc (0001820566) (Issuer)

    8/28/25 4:01:11 PM ET
    $ISPO
    Blank Checks
    Finance

    $API
    $BFRI
    $DNAA
    $EAST
    SEC Filings

    View All

    SEC Form 6-K filed by GSK plc

    6-K - GSK plc (0001131399) (Filer)

    9/18/25 7:17:47 AM ET
    $GSK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 6-K filed by GSK plc

    6-K - GSK plc (0001131399) (Filer)

    9/17/25 6:59:42 AM ET
    $GSK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 6-K filed by GSK plc

    6-K - GSK plc (0001131399) (Filer)

    9/17/25 6:16:27 AM ET
    $GSK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $API
    $BFRI
    $DNAA
    $EAST
    Leadership Updates

    Live Leadership Updates

    View All

    TTEC Digital and VoxEQ Partner to Deliver Real-Time Voice Biometrics in SmartApps Cloud

    The integration with TTEC Digital's proprietary SmartApps Cloud delivers cost-effective, AI-powered fraud prevention to organizations of all sizes AUSTIN, Texas, Sept. 8, 2025 /PRNewswire/ -- TTEC Holdings Inc. (NASDAQ:TTEC) a leading global CX (customer experience) technology and services innovator for AI-enabled CX, today announced a new partnership between TTEC Digital and VoxEQ. "Our partnership with VoxEQ is a game-changer for our SmartApps Cloud clients." - Dave Seybold, CEO, TTEC DigitalThis partnership brings voice biometrics and fraud prevention to SmartApps Cloud, TTEC Digital's proprietary software platform for financial services companies. The integration with VoxEQ marks a signi

    9/8/25 9:25:00 AM ET
    $TTEC
    Professional Services
    Consumer Discretionary

    Biofrontera Inc. Appoints George Jones as Chief Commercial Officer

    Woburn, MA, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Biofrontera Inc. (NASDAQ:BFRI) (the "Company"), a biopharmaceutical company focused on the development and commercialization of photodynamic therapy (PDT), today announced the appointment of George Jones as Chief Commercial Officer (CCO), starting August 25, 2025. In this role, Mr. Jones will oversee the Company's commercial functions, including sales, marketing, and market access. He will report directly to CEO Dr. Hermann Luebbert. This strengthening of the Company's management follows the recent announcement of an agreement to acquire all rights and assets related to Ameluz® and RhodoLED® for the US market, including the FDA approval and al

    8/11/25 4:25:00 PM ET
    $BFRI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    POET Technologies Announces Appointment of Sohail Khan as Director

    TORONTO, July 08, 2025 (GLOBE NEWSWIRE) -- POET Technologies Inc. ("POET" or the "Company") (TSXV:PTK, NASDAQ:POET), the designer and developer of the POET Optical Interposer™, Photonic Integrated Circuits (PICs) and light sources for the data center, tele-communication and artificial intelligence markets, today announced the appointment of Sohail Khan as director and member of the Corporate Governance & Nominating Committee. Mr. Khan's appointment was effective as of Monday, July 7, 2025 and, along with the incumbent five directors of the Company, he will serve until the next annual meeting of shareholders of the Company or until his successor is duly elected or appointed. Mr. Khan is a

    7/8/25 7:34:00 AM ET
    $POET
    Semiconductors
    Technology

    $API
    $BFRI
    $DNAA
    $EAST
    Financials

    Live finance-specific insights

    View All

    Appia Signs Binding Term Sheet to Sell a 45% Interest in Its PCH REE Project, Brazil

    Toronto, Ontario--(Newsfile Corp. - September 2, 2025) - Appia Rare Earths & Uranium Corp. (CSE:API) (OTCQB:APAAF) (FWB: A0I0) (MUN: A0I0) (BER: A0I0) (the "Company" or "Appia") is pleased to announce that it has signed a binding term sheet dated August 29, 2025 (the "Binding Term Sheet") with Beko Invest Ltd. ("Beko"), Antonio Vitor Junior ("Antonio") and Ultra Rare Earth Inc. ("Ultra") to sell a 45% interest in Appia Brasil Rare Earths Mineracao Ltda (the "Appia Brasil"), the Brazilian company that holds the PCH Project (the "Property") located in the Tocantins Structural Province of the Brasília Fold Belt, Goiás State, Brazil, to Ultra.Tom Drivas, CEO of Appia, stated: "Ultra is a Delawar

    9/2/25 10:52:00 AM ET
    $API
    Computer Software: Prepackaged Software
    Technology

    Agora, Inc. Reports Second Quarter 2025 Financial Results

    SANTA CLARA, Calif., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Agora, Inc. (NASDAQ:API) (the "Company"), a pioneer and leader in conversational AI and real-time engagement technology, today announced its unaudited financial results for the second quarter ended June 30, 2025. "We are proud to deliver our third consecutive quarter of GAAP profitability in Q2, with expanding margins driven by solid revenue growth and continued efficiency improvement," said Tony Zhao, Founder, Chairman, and CEO of Agora, Inc. "Since launching our Conversational AI Engine in March, we've partnered with customers to develop voice agents for a variety of applications. We're now seeing several of these solutions enter re

    8/18/25 6:00:00 PM ET
    $API
    Computer Software: Prepackaged Software
    Technology

    Biofrontera Inc. Reports Second Quarter 2025 Financial Results and Provides a Business Update

    Woburn, MA, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Biofrontera Inc. (NASDAQ:BFRI) (the "Company"), a biopharmaceutical company specializing in the development and commercialization of photodynamic therapy in dermatology, today reported financial results for the three and six months ended June 30, 2025 and provided a business update. Highlights from the first six months of 2025 included the following: Total revenues for the second quarter of 2025 were $9.0 million, a 15% increase from the same period of the prior yearFor the first six months of 2025, revenue was $17.7 million, a 12% increase from the comparable period in 2024Cash and cash equivalents were $7.2 million as of June 30, 2025, comp

    8/13/25 5:20:00 PM ET
    $BFRI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $API
    $BFRI
    $DNAA
    $EAST
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Biofrontera Inc.

    SC 13G/A - Biofrontera Inc. (0001858685) (Subject)

    11/14/24 3:54:03 PM ET
    $BFRI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Biofrontera Inc.

    SC 13G/A - Biofrontera Inc. (0001858685) (Subject)

    11/14/24 1:13:39 PM ET
    $BFRI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Biofrontera Inc.

    SC 13G/A - Biofrontera Inc. (0001858685) (Subject)

    11/13/24 2:12:35 PM ET
    $BFRI
    Biotechnology: Pharmaceutical Preparations
    Health Care